<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> candidate region 1 (DSCR1) gene is located on human chromosome 21 and its protein is over-expressed in brains of <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> individuals </plain></SENT>
<SENT sid="1" pm="."><plain>DSCR1 can modulate the activity of calcineurin, a phosphatase abundant in the brain, but its influence on <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome is not clear </plain></SENT>
<SENT sid="2" pm="."><plain>We compared <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome in <z:mp ids='MP_0002169'>wildtype</z:mp> (WT) and transgenic (DSCR1-TG) mice which over-express isoform 1 of human DSCR1 </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was produced by occlusion of the middle cerebral artery for 0.5 h </plain></SENT>
<SENT sid="4" pm="."><plain>After 23.5 h reperfusion, we assessed neurological impairment, brain <z:mpath ids='MPATH_124'>infarct</z:mpath> and <z:hpo ids='HP_0000969'>edema</z:hpo> volume, <z:mp ids='MP_0002498'>leukocyte infiltration</z:mp> and markers of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Intrinsic resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> following <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation was also assessed in primary cultures of WT and DSCR1-TG neurons </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In contrast to WT, DSCR1-TG mice had an improved neurological deficit score, greater grip strength, attenuated <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e>, and lacked hippocampal lesions after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of mouse DSCR1-1, but not DSCR1-4, <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein was increased by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in both WT and DSCR1-TG </plain></SENT>
<SENT sid="8" pm="."><plain>Brain calcineurin activity was increased to a similar degree after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in each genotype </plain></SENT>
<SENT sid="9" pm="."><plain>DSCR1-TG mice had fewer infiltrating neutrophils and activated microglia compared with WT, in association with an attenuated upregulation of several pro-inflammatory genes </plain></SENT>
<SENT sid="10" pm="."><plain>Neurons from DSCR1-TG mice were more resistant than WT neurons to apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> following 24 h of <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Over-expression of DSCR1 in mice improves outcome following <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Mechanisms underlying this protection may involve calcineurin-independent, anti-inflammatory and anti-apoptotic effects mediated by DSCR1 in neurons </plain></SENT>
</text></document>